Epidermal growth factor receptor (EGFR) signaling in the tissue around oral cancers both increases nerve sensitivity and makes opioids less effective, according to new research published in Science ...

But the FDA’s decision does not preclude CMS from determining that the higher dose is not reasonable and necessary — ...

Irene Blair was expected to have another six to eight months to live in June, after her pancreatic cancer rapidly advanced to stage 4 less than a year after her initial diagnosis. A new drug being ...

A subcutaneously injected version of Merck cancer immunotherapy Keytruda is now FDA approved, a regulatory decision that gives patients a less burdensome dosing option and provides the pharmaceutical ...

Costochondritis is not cancer, but its symptoms can resemble those of some types of cancer. It can also develop after certain ...